THE ANABOLICPROTOCOL
SupplementsLow risk

L-Carnitine

Also known as: Carnitine, L-Carnitin, Acetyl-L-Carnitine, ALCAR, L-Carnitine L-Tartrate, LCLT

Sold as a fat burner for decades on a mechanism that is real and an oral dose that mostly never arrives in muscle — the interesting evidence is about recovery, not fat loss.

Substance family

Micronutrients & supplements

Vitamins, minerals, amino acids and enzymes. The recurring pattern: correcting an actual deficiency helps, supplementing beyond a normal level generally does not.

Effects on

Which outcomes this substance acts on — descriptive, not a recommendation.

Strain profile

Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.

Liver
minimal
Kidneys
minimal
Blood lipids
low
Hematocrit
minimal
Blood pressure
minimal
Hormonal axis
minimal

Dosing & protocols by goal

Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.

Recovery and muscle soreness

Basic

Dose

1000–2000 mg L-carnitine L-tartrate / day

Frequency

1–2× daily

Cycle length

Ongoing

The application with the most consistent evidence — reduced markers of muscle damage and less soreness after hard sessions.

Raising muscle carnitine

Advanced

Dose

2000 mg + a high-carbohydrate meal

Frequency

2× daily

Cycle length

12 weeks or more

Muscle uptake requires an insulin spike. Without substantial carbohydrate alongside, oral carnitine raises blood levels and is excreted. This is why most fat-loss trials found nothing.

Fat loss

Not a recommendation

Dose

Frequency

Cycle length

The mechanism is real and the supplement does not deliver it. Carnitine is only rate-limiting when it is deficient, which it is not in someone eating meat. Adding more to a normal system does not accelerate fat oxidation.

Supraphysiological doses carry significant health risks and are not legal without a medical indication. This information serves education and harm reduction, not as a usage recommendation. Accompanying blood work and — where relevant — a post-cycle plan (PCT) are essential. See the disclaimer.

Side effect & countermeasure

Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.

Problem

It is not a fat burner

Countermeasure

The reasoning sounds right: carnitine transports fatty acids into mitochondria, so more should mean more fat burned. It fails because transport is not the bottleneck in anyone with normal carnitine status. Trials in healthy adults consistently show no meaningful fat loss effect. The bottleneck is the energy deficit.

Problem

Muscle uptake needs insulin

Countermeasure

Muscle cells only take up carnitine when insulin is elevated. A capsule on an empty stomach raises blood carnitine and is then excreted in urine. If the goal is raising muscle content, it has to be taken with a substantial carbohydrate meal, twice daily, for months.

Problem

TMAO and cardiovascular risk

Countermeasure

Gut bacteria convert carnitine to TMAO, a metabolite associated with atherosclerosis in observational research. The causal picture is contested, but it deserves mention for a population whose cardiovascular markers are already under pressure from oral compounds. It is an argument against long-term high doses without a clear reason.

Problem

Injectable use

Countermeasure

Injecting carnitine bypasses the absorption problem, which is why it appears in this context. Beyond the sterility and source questions common to any injectable, WADA prohibits infusions above 100 ml per 12 hours — a tested athlete would be committing a violation through the route alone.

Overview

L-Carnitine has been sold as a fat burner for decades, and the mechanism behind that claim is genuinely correct. The claim is still wrong, and understanding why is more useful than the supplement itself.

Mechanism of Action

Fatty acids cannot cross the inner mitochondrial membrane on their own. Carnitine binds them and carries them across, where they are burned for energy. No carnitine, no fat oxidation — the mechanism is not in doubt.

The inference that follows is the problem. More carnitine only means more fat burned if carnitine was the limiting factor, and in anyone eating a normal diet it is not. The body makes it from lysine and methionine, and red meat supplies it directly. The transport system runs well below capacity.

Adding carnitine to a system that is not carnitine-limited is like widening a road that is not congested.

The second obstacle is absorption. Muscle cells take up carnitine only in the presence of elevated insulin. A capsule between meals raises blood carnitine, the kidneys clear it, and muscle content does not move. The studies that did raise muscle carnitine used 2 g twice daily with substantial carbohydrate for twelve weeks or more.

What the Evidence Actually Supports

The recovery data is more interesting than the fat-loss data and gets far less attention.

L-carnitine L-tartrate at 1–2 g daily reduces markers of muscle damage, soreness and perceived exertion after hard training. The proposed mechanism is better blood flow and less oxidative damage to muscle tissue rather than anything to do with fat.

That is a modest but real effect, and it is the honest reason to take this supplement.

Acetyl-L-carnitine crosses the blood-brain barrier and is studied for cognitive endpoints — a separate compound for a separate purpose, not interchangeable with the tartrate form.

The TMAO Question

Gut bacteria metabolise carnitine into TMAO, which observational research links to atherosclerosis. Whether the relationship is causal remains debated, and it is not a reason for alarm.

It is, however, worth weighing here specifically. Anyone running oral compounds already has a suppressed HDL and a rising LDL, and the cardiovascular picture is the main long-term risk on this entire site. Taking a high dose long-term for an effect the evidence does not support is a poor trade in that context.

Side Effects & Risks

  • Digestive upset, nausea
  • A fishy body odour at high doses, from TMA production
  • TMAO formation, of contested cardiovascular relevance
  • Caution with thyroid medication, where it may reduce hormone action
  • Injectable use carries sterility risks and is restricted in tested sport

Blood Work & Monitoring

  • Lipid profile (LDL, HDL, ApoB) — the relevant panel if it is taken long-term
  • No carnitine-specific monitoring is required
  • A deficiency worth correcting is realistic in vegans, in dialysis patients and with certain medications — there, supplementation has a genuine indication

Legal status by region

Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.

RegionRegulatory status
United StatesDietary supplement
EU / UKFood supplement
Most other jurisdictionsFreely available
Competitive sportOral use not prohibitedIntravenous infusions above 100 ml per 12 hours are prohibited by WADA — the restriction is on the route, not the substance.
All content on this page is for information and harm-reduction purposes only. It is not medical advice, not a recommendation to purchase or use, and does not replace consulting a doctor. Legal status and enforcement vary by country and change; verifying the current rules in your own jurisdiction is your responsibility. For adults 18+ only. See the full disclaimer.